Kura Oncology (KURA) Cash from Financing Activities (2010 - 2026)
Kura Oncology (KURA) reported Cash from Financing Activities of $69000.0 for Q1 2026, down 51.75% year-over-year from $143000.0 in Q1 2025, and down 93.92% on a QoQ basis from $1.1 million in Q4 2025.
Kura Oncology (KURA) has 15 years of Cash from Financing Activities data on file, last reported at $69000.0 in Q1 2026.
- Quarterly Cash from Financing Activities fell 51.75% year-over-year to $69000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 72.23% YoY) and the FY2025 annual result came in at $1.8 million, down 98.84% from the prior year.
- Cash from Financing Activities fell to $69000.0 in Q1 2026 per KURA's latest filing, from $1.1 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $148.4 million in Q1 2024 and bottomed at $69000.0 in Q1 2026.
- The 5-year median for Cash from Financing Activities is $843000.0 (2022), against an average of $14.0 million.
- The widest annual swing landed in 2022, when Cash from Financing Activities soared 4271.91%; it then sank 99.9% in 2025.
- Tracing KURA's Cash from Financing Activities over 5 years: stood at $34.7 million in 2022, then tumbled by 98.01% to $691000.0 in 2023, then gained by 16.64% to $806000.0 in 2024, then surged by 40.82% to $1.1 million in 2025, then plunged by 93.92% to $69000.0 in 2026.
- Per Business Quant, the three latest KURA Cash from Financing Activities figures stand at $69000.0 (Q1 2026), $1.1 million (Q4 2025), and $515000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | 69,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69,000.00 |
| Mar 31, 2026 | 69,000.00 |
| Dec 31, 2025 | 1.14 Mn |
| Dec 31, 2025 | 1.14 Mn |
| Jun 30, 2025 | 515,000.00 |
| Jun 30, 2025 | 515,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Dec 31, 2024 | 806,000.00 |
| Dec 31, 2024 | 806,000.00 |
| Sep 30, 2024 | 2.20 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 3.04 Mn |
| Jun 30, 2024 | 3.04 Mn |
| Mar 31, 2024 | 148.37 Mn |
| Mar 31, 2024 | 148.37 Mn |
| Dec 31, 2023 | 691,000.00 |
| Dec 31, 2023 | 691,000.00 |
| Sep 30, 2023 | 84,000.00 |
| Sep 30, 2023 | 84,000.00 |
| Dec 31, 2022 | 34.71 Mn |
| Dec 31, 2022 | 34.71 Mn |
| Sep 30, 2022 | 880,000.00 |
| Sep 30, 2022 | 880,000.00 |
| Jun 30, 2022 | 2.67 Mn |
| Jun 30, 2022 | 2.67 Mn |
| Mar 31, 2022 | 303,000.00 |
| Mar 31, 2022 | 303,000.00 |
| Dec 31, 2021 | 794,000.00 |
| Dec 31, 2021 | 794,000.00 |
| Sep 30, 2021 | 2.26 Mn |
| Sep 30, 2021 | 2.26 Mn |
| Jun 30, 2021 | -6.57 Mn |
| Jun 30, 2021 | -6.57 Mn |
| Mar 31, 2021 | 79,000.00 |
| Mar 31, 2021 | 79,000.00 |
| Dec 31, 2020 | 327.04 Mn |
| Dec 31, 2020 | 327.04 Mn |
| Sep 30, 2020 | 4.68 Mn |
| Sep 30, 2020 | 4.68 Mn |
| Jun 30, 2020 | 137.37 Mn |
| Jun 30, 2020 | 137.37 Mn |
| Mar 31, 2020 | 247,000.00 |
| Mar 31, 2020 | 247,000.00 |
| Dec 31, 2019 | 583,000.00 |
| Dec 31, 2019 | 583,000.00 |
| Sep 30, 2019 | 559,000.00 |
| Sep 30, 2019 | 559,000.00 |
| Jun 30, 2019 | 109.86 Mn |
| Jun 30, 2019 | 109.86 Mn |
| Mar 31, 2019 | 102,000.00 |
| Mar 31, 2019 | 102,000.00 |
| Dec 31, 2018 | 1.14 Mn |
| Dec 31, 2018 | 1.14 Mn |
| Sep 30, 2018 | 73.97 Mn |
| Sep 30, 2018 | 73.97 Mn |
| Jun 30, 2018 | -125,000.00 |
| Jun 30, 2018 | -125,000.00 |
| Mar 31, 2018 | 57.65 Mn |
| Mar 31, 2018 | 57.65 Mn |
| Dec 31, 2017 | -338,000.00 |
| Dec 31, 2017 | -338,000.00 |
| Sep 30, 2017 | 53.71 Mn |
| Sep 30, 2017 | 53.71 Mn |
| Jun 30, 2017 | 189,000.00 |
| Jun 30, 2017 | 189,000.00 |
| Mar 31, 2017 | 5,000.00 |
| Mar 31, 2017 | 5,000.00 |
| Dec 31, 2015 | 50.28 Mn |
| Dec 31, 2015 | 50.28 Mn |
| Sep 30, 2015 | -252,000.00 |
| Sep 30, 2015 | -252,000.00 |
| Jun 30, 2015 | -3.74 Mn |
| Jun 30, 2015 | -3.74 Mn |
| Mar 31, 2015 | 56.58 Mn |
| Mar 31, 2015 | 56.58 Mn |
| Dec 31, 2014 | 2.00 Mn |
| Dec 31, 2014 | 2.00 Mn |
| Sep 30, 2014 | 109,000.00 |
| Sep 30, 2014 | 109,000.00 |
| Jun 30, 2013 | 25,000.00 |
| Jun 30, 2013 | 25,000.00 |
| Mar 31, 2012 | 25,000.00 |
| Mar 31, 2012 | 25,000.00 |
| Dec 31, 2010 | 25,000.00 |
| Dec 31, 2010 | 25,000.00 |